Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma

Yukihiko Kato, Kiyoshi Yoshimura, Tahiro Shin, Henk Verheul, Hans Hammers, Tolib B. Sanni, Brenda C. Salumbides, Karen Van Erp, Richard Schulick, Roberto Pili

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences